However, often occurring in cancer cells, overexpression of Nrf2 due to both genetic and epigenetic mechanisms prompt the searching of naturally occurring compounds that inhibit its activity and expression to avoid chemo -or radiotherapy resistance. Here, NFE2L2 is linked to cancer.